MDXHealth SA's Form 6-K: Key Updates & SEC Compliance Report (Jan 2025)

$MDXH
Form 6-K
Filed on: 2025-01-13
Source
MDXHealth SA's Form 6-K: Key Updates & SEC Compliance Report (Jan 2025)

Here are the key pieces of information extracted from the provided financial report section:

  1. Document Type: Form 6-K - Report of Foreign Private Issuer
  2. Filing Date: January 13, 2025
  3. Company Name: MDXHealth SA
  4. SEC Commission File Number: 001-40996
  5. Address: CAP Business Center, Zone Industrielle des Hauts-Sarts, 4040 Herstal, Belgium
  6. Contact Information: +32 4 257 70 21
  7. Report Purpose: This document is a report filed under Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934.
  8. Annual Report Filing: The company indicates that it will file under Form 20-F and not Form 40-F.
  9. Exhibit Included: The report includes a press release dated January 13, 2025, which is attached as Exhibit 99.1.
  10. Legal Disclaimer: Information in Exhibit 99.1 is being furnished and not deemed "filed" under the Securities Exchange Act of 1934.
  11. Signature: Signed by Michael McGarrity, Chief Executive Officer, on January 13, 2025.

Insights:

  • MDXHealth SA is actively maintaining its compliance with SEC regulations by filing the appropriate forms.
  • The company is headquartered in Belgium, indicating its status as a foreign private issuer.
  • The inclusion of a press release suggests the company may have important updates or announcements that could impact its operations or stock value.
  • The choice of Form 20-F suggests the company is aligning with international reporting standards, which may be beneficial for attracting global investors.